


The Invesco Perpetual European High Income Fund aims to achieve a high level of income and capital growth through a portfolio of primarily European equity and fixed interest securities.
| Name | % Net Assets |
|---|---|
| Roche | 4.3% |
| SLM SEK FRN 15/6/2010 | 2.9% |
| Koninklijke KPN | 2.6% |
| Novartis | 2.2% |
| Vivendi Universal | 1.8% |
| Telekom Austria | 1.8% |
| Rexam 6.75% € Bonds 29/6/2017 | 1.8% |
| GDF Suez | 1.8% |
| Banque Cantonale Vaudoise | 1.8% |
| John Lewis 8.375% £ Bonds 8/4/2019 | 1.7% |
| Key | % Net Assets |
|---|---|
| 4.3% | |
| 2.9% | |
| 2.6% | |
| 2.2% | |
| 88% |
| Date | 19-Aug-2022 |
|---|---|
| NAV | 234.41p |
| Currency | GBP |
| Change | 0.000p |
| % | n/a |
| YTD change | 234.41p |
| YTD % | n/a |
| Fund Inception | 01/05/2008 |
|---|---|
| Fund Manager | n/a |
| TER | 1.01 (31-Dec-2013) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.02% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research